APOE and Alzheimer disease: In the GWAS focusing on APOE ε4 carriers, a discovery cohort including 331 AD patients and 169 healthy subjects and a replication cohort of 190 AD patients and 97 healthy subjects, whose samples were analyzed by WGS and a custom array.